|
[1] JORGE HM,ERAN E,CHENGCHENG J,et al.Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity[J].Nature,2012,482(7384):179-185.
|
|
[2]FAN JG.Epidemiology of alcoholic and nonalcoholic fatty liver disease in China[J].J Gastroenterol Hepatol,2013,28(Suppl 1):11-17.
|
|
[3]DIETRICH P,HELLERBRAND C.Non-alcoholic fatty liver disease,obesity and the metabolic syndrome[J].Best Pract Res Clin Gastroenterol,2014,28(4):637-653.
|
|
[4]RUSU E,JINGA M,ENACHE G,et al.Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C——a randomized trial[J].Nutr J,2013,12:119.
|
|
[5]QU M,SHEN W.Role of PI3K/Akt pathway in endoplasmic reticulum stress and apoptosis induced by saturated fatty acid in human steatotic hepatocytes[J].Chin J Hepatol,2015,23(3):194-199.(in Chinese)瞿梅,沈薇.PI3K/Akt对饱和脂肪酸诱导肝细胞脂变内质网应激及脂性凋亡的影响[J].中华肝脏病杂志,2015,23(3):194-199.
|
|
[6]GARCA-RUIZ I,SOLS-MUOZ P,FERNNDEZ-MOREIRA D,et al.In vitro treatment of Hep G2 cells with saturated fatty acids reproduces mitochondrial dysfunction found in nonalcoholic steatohepatitis[J].Dis Model Mech,2015,8(2):183-191.
|
|
[7]GENTILE CL,PAGLIASSOTTI MJ.The role of fatty acids in the development and progression of nonalcoholic fatty liver disease[J].J Nutr Biochem,2008,19(9):567-576.
|
|
[8]ZIVKOVIC AM,GERMAN JB,SANYAL AJ.Comparative review of diets for the metabolic syndrome:implications for nonalcoholic fatty liver disease[J].Am J Clin Nutr,2007,86(2):285-300.
|
|
[9]BENATAR JR,STEWART RA.The effects of changing dairy intake on trans and saturated fatty acid levels-results from a randomized controlled study[J].Nutr J,2014,13(8):32-42.
|
|
[10]MACHADO RM,STEFANO JT,OLIVEIRA CP,et al.Intake of trans fatty acids causes nonalcoholic steatohepatitis and reduces adipose tissue fat content[J].J Nutr,2010,140(6):1127-1132.
|
|
[11]DHIBI M,BRAHMI F,MNARI A,et al.The intake of high fat diet with different trans fatty acid levels differentially induces oxidative stress and non alcoholic fatty liver disease(NAFLD)in rats[J].Nutr Metab(Lond),2011,8(1):65-77.
|
|
[12]de ALMEIDA MM,LUQUETTI SC,SABARENSE CM,et al.Butter naturally enriched in cis-9,trans-11 CLA prevents hyperinsulinemia and increases both serum HDL cholesterol and triacylglycerol levels in rats[J].Lipids Health Dis,2014,13:200.
|
|
[13]PRIORE P,CAVALLO A,GNONI A,et al.Modulation of hepatic lipid metabolism by olive oil and its phenols in nonalcoholic fatty liver disease[J].IUBMB Life,2015,67(1):9-17.
|
|
[14]BARGUT TC,FRANTZ ED,MANDARIM-de-LACERDA CA,et al.Effects of a diet rich in n-3 polyunsaturated fatty acids on hepatic lipogenesis and beta-oxidation in mice[J].Lipids,2014,49(5):431-444.
|
|
[15]PICKOVA J.Importance of knowledge on lipid composition of foods to support development towards consumption of higher levels of n-3fatty acids via freshwater fish[J].Physiol Res,2009,58(Suppl1):s39-s45.
|
|
[16]ARENDT BM,COMELLI EM,MA DW,et al.Altered hepatic gene expression in non-alcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids[J].Hepatology,2015,61(5):1565-1578.
|
|
[17]VOS MB,Mc CLAIN CJ.Nutrition and nonalcoholic fatty liver disease in children[J].Curr Diab Rep,2008,8(5):399-406.
|
|
[18]MELLOUK Z,HACHIMI IDRISSI T,LOUCHAMI K,et al.The metabolic syndrome of fructose-fed rats:effects of long-chain polyunsaturatedω3 andω6 fatty acids.I.Intraperiteneal glucose tolerance test[J].Int J Mol Med,2011,28(6):1087-1092.
|
|
[19]BRAY GA.Soft drink consumption and obesity:it is all about fructose[J].Curr Opin Lipidol,2010,21(1):51-57.
|
|
[20]FAN JG,CAO HX.Role of diet and nutritional management in non-alcoholic fatty liver disease[J].J Gastroenterol Hepatol,2013,28(Suppl 4):81-87.
|
|
[21]ZHANG J,LI L,SONG P,et al.Randomized controlled trial of oatmeal consumption nersus noodle consumption on blood lipids of urban Chinese adults with hypercholesterolemia[J].Nutr J,2012,11(1):54-62.
|
|
[22]BELLENTANI S,DALLE GRAVE R,SUPPINI A,et al.Behavior therapy for nonalcoholic fatty liver disease:the need for a multidisciplinary approach[J].Hepatology,2008,47(2):746-754.
|
|
[23]ALUKO EO,NNA VU,ADEKUNBI DA.The possible mechanisms through which dietary protein increases renal blood flow and glomerular filtration rate[J].Bri J Med Med Res,2015,7(6):458-469.
|
|
[24]BARCHETTA I,ANGELICO F,de BEN MD,et al.Strong association between non alcoholic fatty liver disease(NAFLD)and low 25(OH)vitamin D levels in an adult population with normal serum liver enzymes[J].BMC Med,2011,9:85.
|
|
[25]SEYDEL S,BEILFUSS A,KAHRAMAN A,et al.Vitamin D ameliorates stress ligand expression elicited by free fatty acids in the hepatic stellate cell line LX-2[J].Turk J Gastroenterol,2011,22(4):400-407.
|
|
[26]KWOK RM,TORRES DM,HARRISON SA.Vitamin D and nonalcoholic fatty liver disease(NAFLD):is it more than just an association?[J].Hepatology,2013,58(3):1166-1174.
|
|
[27]ROLO AP,TEODORO JS,PALMEIRA CM.Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis[J].Free Radic Biol Med,2012,52(1):59-69.
|
|
[28]MUSSO G,ANTY R,PETTA S.Antioxidant therapy and drugs interfering with lipid metabolism:could they be effective in NAFLD patients?[J].Curr Pharm Des,2013,19(29):5297-5313.
|
|
[29]SHU X,ZHANG L,JI G.Vitamin E therapy in non-alcoholic fatty liver disease[J].Int J Clin Med,2014,5:87-92.
|
|
[30]BASU PP,SHAH NJ,ALOYSIUS MM,et al.Effect of vitamin E and alpha lipoic acid in nonalcoholic fatty liver disease:a randomized,placebo-controlled,open-label,prospective clinical trial(VAIN Trial)[J].Open J Gastroenterol,2014,4(5):199-207.
|
|
[31]CHALASANI N,YOUNOSSI Z,LAVINE JE,et al.The diagnosis and management of non-alcoholic fatty liver disease:practice guideline by the American Gastroenterological Association,American Association for the Study of Liver Diseases,and American College of Gastroenterology[J].Gastroenterology,2012,142(7):1592-609.
|
|
[32]LI Q,ZHUO QB,CHEN L,et al.Research advances in treatment of non-alcoholic fatty liver disease[J].J Clin Hepatol,2015,31(7):1135-1139.(in Chinese)李强,卓其斌,陈良,等.非酒精性脂肪性肝病的治疗进展[J].临床肝胆病杂志,2015,31(7):1135-1139.
|
|
[33]HUANG WS,WANG W.Basic management of nonalcoholic fatty liver disease[J].J Clin Hepatol,2010,26(2):156-159.(in Chinese)黄伟燊,王威.非酒精性脂肪肝病的基本管理[J].临床肝胆病杂志,2010,26(2):156-159.
|
DownLoad: